$KANT
KINETA, INC./DE Stock $kant

$kant Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000095017023011364 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$281.0K	-$2.130M	$1.953M
YoY Change	-72.53%	-379.53%	-75.72%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$3.920M	-$5.870M	$8.700M
YoY Change	-18.76%	-215.05%	-57.31%
% of Gross Profit
Research & Development	$2.843M	$28.03M	$15.93M
YoY Change	-41.93%	393.4%	-39.69%
% of Gross Profit
Depreciation & Amortization	$2.000K	-$40.00K	$73.00K
YoY Change	-96.97%	-133.9%	-87.83%
% of Gross Profit
Operating Expenses	$6.767M	$22.16M	$43.48M
YoY Change	-50.32%	105.51%	-7.06%
Operating Profit	-$6.486M		-$41.53M
YoY Change	-48.52%		7.19%
Interest Expense	$23.00K	-$3.520M	$3.737M
YoY Change	-89.05%	758.54%	105.67%
% of Operating Profit
Other Income/Expense, Net	$6.000K	-$18.50M	-$21.92M
YoY Change	-100.77%	-92600.0%	2792.08%
Pretax Income	-$6.480M	-$41.86M	-$63.45M
YoY Change	-51.57%	302.07%	60.62%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$6.451M	-$41.82M	-$63.41M
YoY Change	-51.79%	301.69%	60.51%
Net Earnings / Revenue	-2295.73%		-3246.7%
Basic Earnings Per Share	-$0.77		-$12.87
Diluted Earnings Per Share	-$0.77	-$2.75	-$12.87
COMMON SHARES
Basic Shares Outstanding	8.501M	10.86M	4.926M
Diluted Shares Outstanding	8.361M		4.926M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.200M	$13.10M	$13.10M
YoY Change	-47.43%	-64.11%	-64.11%
Cash & Equivalents	$9.363M	$13.27M
Short-Term Investments
Other Short-Term Assets	$300.0K	$500.0K	$500.0K
YoY Change	-89.85%	-58.57%	-58.57%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$9.569M	$13.60M	$13.60M
YoY Change	-53.13%	-68.16%	-68.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$72.00K	$249.0K	$3.700M
YoY Change	-60.44%	-35.66%	-80.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$100.0K	$100.0K	$100.0K
YoY Change	-88.61%	-89.22%	-89.22%
Total Long-Term Assets	$3.481M	$3.835M	$3.800M
YoY Change	-68.76%	-81.04%	-81.21%
TOTAL ASSETS
Total Short-Term Assets	$9.569M	$13.60M	$13.60M
Total Long-Term Assets	$3.481M	$3.835M	$3.800M
Total Assets	$13.05M	$17.44M	$17.40M
YoY Change	-58.65%	-72.3%	-72.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$9.835M	$6.635M	$6.600M
YoY Change	372.84%	260.79%	258.89%
Accrued Expenses	$1.052M	$3.527M	$4.400M
YoY Change	-63.37%	-27.22%	-55.6%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$11.96M	$11.49M	$11.50M
YoY Change	11.3%	-49.31%	-49.26%
LONG-TERM LIABILITIES
Long-Term Debt	$800.0K	$800.0K	$800.0K
YoY Change		-89.13%	-89.13%
Other Long-Term Liabilities	$300.0K	$500.0K	$500.0K
YoY Change	-96.71%	-94.69%	-94.69%
Total Long-Term Liabilities	$1.100M	$1.300M	$1.300M
YoY Change		-82.33%	-92.25%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.96M	$11.49M	$11.50M
Total Long-Term Liabilities	$1.100M	$1.300M	$1.300M
Total Liabilities	$13.11M	$12.87M	$13.00M
YoY Change	-33.99%	-67.38%	-67.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$158.1M	-$151.7M
YoY Change	-21.23%	-19.01%
Common Stock	$9.000K	$8.000K
YoY Change	-18.18%	-27.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$173.0K	$4.424M	$4.400M
YoY Change
Total Liabilities & Shareholders Equity	$13.05M	$17.44M	$17.40M
YoY Change	-58.65%	-72.3%	-72.35%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$6.451M	-$41.82M	-$63.41M
YoY Change	-51.79%	301.69%	60.51%
Depreciation, Depletion And Amortization	$2.000K	-$40.00K	$73.00K
YoY Change	-96.97%	-133.9%	-87.83%
Cash From Operating Activities	-$4.940M	-$2.230M	-$19.03M
YoY Change	-36.9%	-74.48%	-61.1%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$20.00K	$71.00K
YoY Change	-100.0%	-183.33%	-48.55%
Acquisitions
YoY Change
Other Investing Activities	$290.0K	$7.680M	$9.340M
YoY Change		373.2%	189.07%
Cash From Investing Activities	$285.0K	$7.660M	$9.270M
YoY Change	-637.74%	379.05%	199.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$1.581M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	750.0K	24.19M	11.81M
YoY Change	-106.69%	-1972.29%	-1243.08%
NET CHANGE
Cash From Operating Activities	-4.940M	-2.230M	-19.03M
Cash From Investing Activities	285.0K	7.660M	9.270M
Cash From Financing Activities	750.0K	24.19M	11.81M
Net Change In Cash	-3.905M	29.62M	2.049M
YoY Change	-79.55%	-451.36%	-104.37%
FREE CASH FLOW
Cash From Operating Activities	-$4.940M	-$2.230M	-$19.03M
Capital Expenditures	$0.00	$20.00K	$71.00K
Free Cash Flow	-$4.940M	-$2.250M	-$19.10M
YoY Change	-37.33%	-74.18%	-61.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	WA
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001445283
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Entity Registrant Name EntityRegistrantName	KINETA, INC./DE
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-37695
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8436652
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	219 Terry Ave. N.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Seattle
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	98109
CY2022	dei	City Area Code CityAreaCode	206
CY2022	dei	Local Phone Number LocalPhoneNumber	378-0400
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	KA
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	18100000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	8501366
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Cash Cash	13143000
CY2021Q4	us-gaap	Cash Cash	11144000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	457000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	73000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13600000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	11217000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1211000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1872000
CY2022Q4	ka	Rights From Private Placement RightsFromPrivatePlacement	2250000
CY2021Q4	ka	Rights From Private Placement RightsFromPrivatePlacement	0
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	125000
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	75000
CY2022Q4	us-gaap	Assets Assets	17435000
CY2021Q4	us-gaap	Assets Assets	13353000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6635000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	732000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3527000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1842000
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	442000
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1041000
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	0
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	8378000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9996000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	843000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	737000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	40000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	30000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11487000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14378000
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	0
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	8378000
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	748000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	9444000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	547000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1390000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	83000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	90000
CY2022Q4	us-gaap	Liabilities Liabilities	12865000
CY2021Q4	us-gaap	Liabilities Liabilities	25302000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8318000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8318000
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4656000
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4656000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	8000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	5000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	156106000
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	76137000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151690000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88282000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4424000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12140000
CY2022Q4	us-gaap	Minority Interest MinorityInterest	146000
CY2021Q4	us-gaap	Minority Interest MinorityInterest	191000
CY2022	ka	Issuance Of Common Stock Value Upon Exercise Of Warrants IssuanceOfCommonStockValueUponExerciseOfWarrants	71000
CY2022	ka	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	62000
CY2022	ka	Issuance Of Warrants In Connection With Convertible Debt Amendments IssuanceOfWarrantsInConnectionWithConvertibleDebtAmendments	1639000
CY2022	ka	Issuance Of Warrants To Existing Stockholders IssuanceOfWarrantsToExistingStockholders	3309000
CY2022	ka	Adjustments To Additional Paid In Capital Note Conversion Discount AdjustmentsToAdditionalPaidInCapitalNoteConversionDiscount	414000
CY2022	ka	Adjustments To Additional Paid In Capital Common Stock Tranche Asset AdjustmentsToAdditionalPaidInCapitalCommonStockTrancheAsset	2250000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4570000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11949000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17435000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13353000
CY2022	us-gaap	Revenues Revenues	1953000
CY2021	us-gaap	Revenues Revenues	9091000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15928000
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15561000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8696000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4623000
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	18860000
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	0
CY2022	us-gaap	Operating Expenses OperatingExpenses	43484000
CY2021	us-gaap	Operating Expenses OperatingExpenses	20184000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-41531000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-11093000
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	1659000
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	893000
CY2022	us-gaap	Interest Expense InterestExpense	3737000
CY2021	us-gaap	Interest Expense InterestExpense	1293000
CY2022	ka	Gain Loss On Fair Value Measurement Notes Payable GainLossOnFairValueMeasurementNotesPayable	-15280000
CY2021	ka	Gain Loss On Fair Value Measurement Notes Payable GainLossOnFairValueMeasurementNotesPayable	-1142000
CY2022	ka	Warrant Expense WarrantExpense	3309000
CY2021	ka	Warrant Expense WarrantExpense	0
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	341000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1719000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	63000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21922000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-724000
CY2022	us-gaap	Profit Loss ProfitLoss	-63453000
CY2021	us-gaap	Profit Loss ProfitLoss	-11817000
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-45000
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-63408000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11817000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.87
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.87
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.71
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.71
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4926000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4926000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4358000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4358000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-21546000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16713000
CY2021	ka	Issuance Of Common Stock Value Upon Extinguishment Of Note Payable IssuanceOfCommonStockValueUponExtinguishmentOfNotePayable	2570000
CY2021	ka	Issuance Of Common Stock Value To Settle Obligation IssuanceOfCommonStockValueToSettleObligation	250000
CY2021	ka	Issuance Of Common Stock Value Upon Exercise Of Warrants IssuanceOfCommonStockValueUponExerciseOfWarrants	27000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1854000
CY2021	us-gaap	Profit Loss ProfitLoss	-11817000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-11949000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1581000
CY2022	ka	Issuance Of Common Stock Value Upon Extinguishment Of Note Payable IssuanceOfCommonStockValueUponExtinguishmentOfNotePayable	37519000
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	20551000
CY2022	ka	Issuance Of Common Stock In Connection With Private Placement Net Of Transaction Costs IssuanceOfCommonStockInConnectionWithPrivatePlacementNetOfTransactionCosts	7407000
CY2022	ka	Non Cash Stock Based Compensation NonCashStockBasedCompensation	5169000
CY2022	us-gaap	Profit Loss ProfitLoss	-63453000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4570000
CY2022	us-gaap	Profit Loss ProfitLoss	-63453000
CY2021	us-gaap	Profit Loss ProfitLoss	-11817000
CY2022	ka	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	18860000
CY2021	ka	Acquired In Process Research And Development AcquiredInProcessResearchAndDevelopment	0
CY2022	ka	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	15280000
CY2021	ka	Change In Fair Value Of Notes Payable ChangeInFairValueOfNotesPayable	1142000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	5169000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1854000
CY2022	ka	Warrant Expense WarrantExpense	3309000
CY2022	ka	Issuance Of Warrants In Connection With Convertible Debt Amendments IssuanceOfWarrantsInConnectionWithConvertibleDebtAmendments	1639000
CY2021	ka	Issuance Of Warrants In Connection With Convertible Debt Amendments IssuanceOfWarrantsInConnectionWithConvertibleDebtAmendments	0
CY2022	ka	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	661000
CY2021	ka	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	590000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	73000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79000
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	62000
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	0
CY2022	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	341000
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	1719000
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	62000
CY2021	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	108000
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	18000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-34000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-178000
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1694000
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	739000
CY2022	ka	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-737000
CY2021	ka	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-642000
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1041000
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-7883000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19029000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-17853000
CY2022	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	9276000
CY2021	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	71000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	65000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	9270000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	7407000
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	6746000
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1581000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16713000
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	71000
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	27000
CY2022	ka	Proceeds From Payroll Protection Program Loan ProceedsFromPayrollProtectionProgramLoan	0
CY2021	ka	Proceeds From Payroll Protection Program Loan ProceedsFromPayrollProtectionProgramLoan	815000
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4000000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0
CY2022	ka	Repayments Of Finance Lease Liabilities RepaymentsOfFinanceLeaseLiabilities	-3000
CY2021	ka	Repayments Of Finance Lease Liabilities RepaymentsOfFinanceLeaseLiabilities	28000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11808000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17527000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2049000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-326000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11219000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11545000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13268000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11219000
CY2022Q4	us-gaap	Cash Cash	13143000
CY2021Q4	us-gaap	Cash Cash	11144000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	125000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	75000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13268000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11219000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2371000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1100000
CY2022	us-gaap	Stock Issued1 StockIssued1	20551000
CY2021	us-gaap	Stock Issued1 StockIssued1	0
CY2022	ka	Issuance Of Common Stock Upon Extinguishment Of Notes Payable IssuanceOfCommonStockUponExtinguishmentOfNotesPayable	22239000
CY2021	ka	Issuance Of Common Stock Upon Extinguishment Of Notes Payable IssuanceOfCommonStockUponExtinguishmentOfNotesPayable	2570000
CY2022	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	1944000
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0
CY2022	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	2250000
CY2021	us-gaap	Payments For Repurchase Of Private Placement PaymentsForRepurchaseOfPrivatePlacement	0
CY2022	ka	Finance Lease Liabilities Arising From Obtaining New Right Of Use Assets FinanceLeaseLiabilitiesArisingFromObtainingNewRightOfUseAssets	40000
CY2021	ka	Finance Lease Liabilities Arising From Obtaining New Right Of Use Assets FinanceLeaseLiabilitiesArisingFromObtainingNewRightOfUseAssets	27000
CY2022	ka	Issuance Of Common Stock Upon Payable Settlement IssuanceOfCommonStockUponPayableSettlement	0
CY2021	ka	Issuance Of Common Stock Upon Payable Settlement IssuanceOfCommonStockUponPayableSettlement	250000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151700000
CY2022	us-gaap	Profit Loss ProfitLoss	-63500000
CY2022Q4	us-gaap	Cash Cash	13100000
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. These estimates form the basis for judgments the Company makes about the carrying values of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting periods. The Company bases its estimates and judgments on historical experience and on various other assumptions that the Company believes are reasonable under the circumstances. These estimates are based on management’s knowledge about current events and expectations about actions the Company may undertake in the future. These judgments, estimates and assumptions are used for, but not limited to, revenue recognition, accrued research and development expenses, the fair value of notes payable, the fair value of the Company’s common stock prior to the Merger, stock-based compensation, uncertain tax positions and the valuation allowance for net deferred tax assets. Actual results may differ from the Company’s estimates.</span></p>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Concentrations of Credit Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Financial instruments that potentially expose the Company to significant concentrations of credit risk consist primarily of cash deposited in accounts at several financial institutions that may exceed federally insured limits. The Company is exposed to credit risk in the event of a default by the financial institutions holding its cash to the extent recorded in the consolidated balance sheets. The Company believes it is not exposed to unusual credit risk beyond the normal credit risk associated with commercial banking relationships and has not incurred any such losses to date.</span></p>
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.14
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	17830000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	18102000
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	6746000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	0
CY2022	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Notes Payable FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInNotesPayable	-15280000
CY2021	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Notes Payable FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInNotesPayable	1142000
CY2022	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Debt Extinguishment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInDebtExtinguishment	-673000
CY2021	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Change In Debt Extinguishment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityChangeInDebtExtinguishment	0
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-4000000
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	0
CY2022	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Notes Payable FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfNotesPayable	-34964000
CY2021	ka	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Notes Payable FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfNotesPayable	-1414000
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	219000
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	17830000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	866000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1140000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	617000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	951000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	249000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100000
CY2022	us-gaap	Proceeds From Sale Of Foreclosed Assets ProceedsFromSaleOfForeclosedAssets	400000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2176000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	99000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	745000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	790000
CY2022Q4	ka	Accrued Clinical Trial And Preclinical Costs AccruedClinicalTrialAndPreclinicalCosts	404000
CY2021Q4	ka	Accrued Clinical Trial And Preclinical Costs AccruedClinicalTrialAndPreclinicalCosts	641000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	132000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	280000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	70000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	32000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3527000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1842000
CY2022Q4	us-gaap	Notes Payable NotesPayable	779000
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	748000
CY2021Q4	us-gaap	Notes Payable NotesPayable	16960000
CY2021Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	19440000
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	9996000
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	748000
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	9444000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	629000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	2000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	148000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	779000
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0
CY2022Q4	us-gaap	Notes Payable NotesPayable	779000
CY2020Q4	us-gaap	Revenues Revenues	3000000.0
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4000000.0
CY2022	ka	Fair Value Of Warrants Issued FairValueOfWarrantsIssued	21800
CY2022Q4	ka	Non Voting Common Shares Issued NonVotingCommonSharesIssued	754000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	937000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	561000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1498000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	108000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1390000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	843000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	547000
CY2022	ka	Schedule Of Operating Leases Supplemental Information ScheduleOfOperatingLeasesSupplementalInformation	<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Supplemental information on the Company's operating leases was as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:60.774%;"/> <td style="width:2.38%;"/> <td style="width:1.0%;"/> <td style="width:15.233%;"/> <td style="width:1.0%;"/> <td style="width:2.392%;"/> <td style="width:1.0%;"/> <td style="width:15.222000000000001%;"/> <td style="width:1.0%;"/> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">December 31,</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:7.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2021</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Cash paid for operating lease agreement (in thousands)</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">909</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">$</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">883</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Remaining lease term (in years)</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">1.6</span></span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">2.6</span></span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">Incremental borrowing rate</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Times New Roman", serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">10</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:nowrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);font-weight:normal;font-size:9.0pt;font-family:"Times New Roman", serif;min-width:fit-content;">%</span></p></td> </tr> </table>
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	909000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	883000
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.10
CY2022	us-gaap	Sublease Income SubleaseIncome	200000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	50000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	50000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	32000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	9000
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	141000
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	18000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	123000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	40000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	83000
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y2M12D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.093
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.094
CY2022	ka	Milestones Achieved MilestonesAchieved	0
CY2022	ka	Royalties Due RoyaltiesDue	0
CY2022	ka	Milestones Achieved MilestonesAchieved	0
CY2022	ka	Royalties Due RoyaltiesDue	0
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	338000
CY2022	ka	Warrant Or Rights Issued WarrantOrRightsIssued	716000
CY2022	ka	Warrant Or Rights Exercised WarrantOrRightsExercised	-53000
CY2022	ka	Warrant Or Rights Cancelled Or Expired WarrantOrRightsCancelledOrExpired	-468000
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	533000
CY2022Q3	ka	Common Stock Warrants Issued CommonStockWarrantsIssued	2000
CY2022Q3	ka	Common Stock Purchased For Professional Services CommonStockPurchasedForProfessionalServices	62000
CY2022	ka	Warrant Expense WarrantExpense	3300000
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1576000
CY2021Q4	ka	Licensing Revenue Agreement Beginning Balance LicensingRevenueAgreementBeginningBalance	1041000
CY2020Q4	ka	Licensing Revenue Agreement Beginning Balance LicensingRevenueAgreementBeginningBalance	8924000
CY2022	ka	Increase Due To Acquisition IncreaseDueToAcquisition	442000
CY2021	ka	Increase Due To Acquisition IncreaseDueToAcquisition	0
CY2022	ka	Decrease For Provision Of Research Services DecreaseForProvisionOfResearchServices	-1041000
CY2021	ka	Decrease For Provision Of Research Services DecreaseForProvisionOfResearchServices	-7883000
CY2022Q4	ka	Licensing Revenue Agreement Ending Balance LicensingRevenueAgreementEndingBalance	442000
CY2021Q4	ka	Licensing Revenue Agreement Ending Balance LicensingRevenueAgreementEndingBalance	1041000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	703000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.95
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4100000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	97000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	27.03
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	11000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	9.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	51000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	25.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	5000
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.16
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	733000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.67
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y4M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3721000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	575000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	21.37
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	3616000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	143000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.98
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	37000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.47
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	5000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	31.25
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	175000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.10
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5188000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1854000
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	19000
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1900000
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M12D
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6923000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2326000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6923000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2326000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	ka	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development Tax Credit Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditPercent	0.008
CY2021	ka	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development Tax Credit Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopmentTaxCreditPercent	0.009
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.109
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.197
CY2022	ka	Effective Income Tax Rate Reconciliation Debt Fair Value Adjustment EffectiveIncomeTaxRateReconciliationDebtFairValueAdjustment	-0.049
CY2021	ka	Effective Income Tax Rate Reconciliation Debt Fair Value Adjustment EffectiveIncomeTaxRateReconciliationDebtFairValueAdjustment	-0.020
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.000
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	-0.044
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.000
CY2022	ka	Transaction Costs TransactionCosts	-0.019
CY2021	ka	Transaction Costs TransactionCosts	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.002
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	144729000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12362000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	22384000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	1889000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3586000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1353000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	914000
CY2022Q4	ka	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	318000
CY2021Q4	ka	Deferred Tax Assets Leasing Arrangements DeferredTaxAssetsLeasingArrangements	472000
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	316000
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	316000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	103000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	70000
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	61000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	172850000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	16023000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	172637000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	14146000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	213000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1877000
CY2022Q4	ka	Deferred Tax Liabilities Partnership Basis Deferred DeferredTaxLiabilitiesPartnershipBasisDeferred	85000
CY2021Q4	ka	Deferred Tax Liabilities Partnership Basis Deferred DeferredTaxLiabilitiesPartnershipBasisDeferred	-1413000
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	280000
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	419000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	18000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other Finite Lived Assets DeferredTaxLiabilitiesOtherFiniteLivedAssets	45000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	213000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1877000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	158500000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2300000
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	540900000
CY2022Q4	ka	Operating Loss Carryforwards Expiration Amount OperatingLossCarryforwardsExpirationAmount	303700000
CY2022Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	23200000
CY2022	us-gaap	Tax Credit Carryforward Limitations On Use TaxCreditCarryforwardLimitationsOnUse	expire in 2028
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3600000
CY2022Q3	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.15
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	630000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	593000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	198000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	37000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	828000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	630000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-63408000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-11817000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4926000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4926000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4358000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4358000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.87
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.87
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.71
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.71
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1497000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1831000
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	100000
CY2022	ka	Common Stock Offering Amount CommonStockOfferingAmount	60000000.0

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-23-011364-index-headers.html	Edgar Link	pending
0000950170-23-011364-index.html	Edgar Link	pending
0000950170-23-011364.txt	Edgar Link	pending
0000950170-23-011364-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img146924756_0.jpg	Edgar Link	pending
img146924756_1.jpg	Edgar Link	pending
img146924756_10.jpg	Edgar Link	pending
img146924756_11.jpg	Edgar Link	pending
img146924756_12.jpg	Edgar Link	pending
img146924756_13.jpg	Edgar Link	pending
img146924756_14.jpg	Edgar Link	pending
img146924756_15.jpg	Edgar Link	pending
img146924756_16.jpg	Edgar Link	pending
img146924756_17.jpg	Edgar Link	pending
img146924756_18.jpg	Edgar Link	pending
img146924756_19.jpg	Edgar Link	pending
img146924756_2.jpg	Edgar Link	pending
img146924756_3.jpg	Edgar Link	pending
img146924756_4.jpg	Edgar Link	pending
img146924756_5.jpg	Edgar Link	pending
img146924756_6.jpg	Edgar Link	pending
img146924756_7.jpg	Edgar Link	pending
img146924756_8.jpg	Edgar Link	pending
img146924756_9.jpg	Edgar Link	pending
ka-20221231.htm	Edgar Link	pending
ka-20221231.xsd	Edgar Link	pending
ka-ex10_18.htm	Edgar Link	pending
ka-ex21_1.htm	Edgar Link	pending
ka-ex23_1.htm	Edgar Link	pending
ka-ex31_1.htm	Edgar Link	pending
ka-ex31_2.htm	Edgar Link	pending
ka-ex32_1.htm	Edgar Link	pending
ka-ex4_2.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
ka-20221231_cal.xml	Edgar Link	unprocessable
ka-20221231_def.xml	Edgar Link	unprocessable
ka-20221231_lab.xml	Edgar Link	unprocessable
ka-20221231_pre.xml	Edgar Link	unprocessable
ka-20221231_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KANT
KINETA, INC./DE Stock $kant

2023 Q1 Form 10-K Financial Statement

#000095017023011364 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KANT KINETA, INC./DE Stock $kant

2023 Q1 Form 10-K Financial Statement

#000095017023011364 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KANT
KINETA, INC./DE Stock $kant